Magle Chemoswed Holding Ab
Research Magle Chemoswed Holding Ab (MAGLE) on Bullrun: market cap SEK 20.86M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMAGLE
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencySEK
- Market capSEK 20.86M
- Financial periodQ4 2025
- RevenueSEK 77.70M
- Net income-SEK 134.04M
- Free cash flow-SEK 2.52M
- Gross margin26.1%
Valuation Snapshot
latest market cap is SEK 20.86M.
About Magle Chemoswed Holding Ab
Magle Chemoswed Holding AB (publ), together with its subsidiaries, engages in research and development of pharmaceutical and medical device products in Sweden. It provides warfarin sodium products used as anticoagulants for multiple indications; melperone hydrochloride, which is an antipsychotic agent; isradipine, a calcium channel blocker used to treat hypertension; and benserazide hydrochloride, which is used in combination with L-Dopa in the treatment of Parkinson's disease.
Frequently asked questions
What is Magle Chemoswed Holding Ab's market cap?
Magle Chemoswed Holding Ab's market capitalization is SEK 20.86M.
What does Magle Chemoswed Holding Ab do?
Magle Chemoswed Holding AB (publ), together with its subsidiaries, engages in research and development of pharmaceutical and medical device products in Sweden. It provides warfarin sodium products used as anticoagulants for multiple indications;